February 26, 2024
Shionogi said on February 22 that it has obtained Taiwanese regulatory approval for its siderophore cephalosporin antibiotic Fetroja (cefiderocol) through its local subsidiary. The approval was granted for the treatment of complicated urinary tract infections, including pyelonephritis, and hospital-acquired pneumonia...read more